[Retracted] Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification

Table 1

The clinicopathological parameters of patients with lung cancer.

Characteristics	HS (n = 50)	LC			value (HS vs. LC)
		SCLC (n = 50)	LUAD (n = 50)	LUSC (n = 50)
Age in years median (range)	69.98 ± 11.25	70.26 ± 12.05	74.14 ± 8.76	71.96 ± 11.72	0.237
Gender					0.280
Male	33	35	28	23
Female	17	15	22	27
Smoking status					0.612
Yes	30	36	32	28
No	20	14	18	22
Stage					—
I-II	—	19	16	18
III-IV	—	31	34	32
Lymph metastasis
No	—	16	14	15	—
Yes	—	34	36	35
Distal metastasis					—
Yes	—	16	18	14
No	—	34	32	36

HS, healthy subjects; LC, lung cancer; SCLC, small cell lung cancer; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma.